CBI provides integrated solutions to global health
CBI Programs

Biomanufacturing@MIT-CBI focuses on technology, training, and knowledge networks in biomanufacturing to advance the safe, timely, and efficient production and delivery of biologic medicines.

MIT NEWDIGS is a global multi-stakeholder “think and do” tank focused on re-engineering drug therapy development, access, and use to be more patient-centered and economically sustainable.
Upcoming Events
Biomanufacturing@MIT-CBI
Feb 16 - 19 2021
2021 Vaccines Bioprocess Development & Commercialization Short Course
Online Event
Feb 24 2021
Biomanufacturing@MIT-CBI Research Seminar Series 2021
Online Event
No event found!
NEWDIGS
Apr 27 - 29 2021
FoCUS Design Lab
Cambridge
Jun 10 - 11 2021
LEAPS Design Lab
Cambridge, MA
No event found!
Latest News & Research

Enroll in MIT xPro Course through March 3rd!
Our Principles of Biomanufacturing: Using Biotechnology to Manufacture Medicines online course has just launched. This six-week self-paced course offers scientists,…

NEWDIGS offers comment on CMS Proposed Rule supporting Value-Based Purchasing, July 20th, 2020
On behalf of the NEWDIGS initiative / FoCUS Project, team members submitted comments on the recent CMS Proposed Rule supporting Value-Based Purchasing (VBP)…

Nature Biotechnology publishes CAACB Article on Viral Contamination in Biologic Manufacture and Implications for Emerging Therapies
This report, made possible through the efforts of our consortium members, offers lessons learned to help prevent viruses from contaminating…
Our Team
CBI’s core strength is in our team’s cross-cutting experience and expertise in medicine, biology, chemistry, biomanufacturing, academic & clinical research, economics, engineering, data analytics, regulatory science and public policy.
Slider shortcode: [smartslider3 slider="14"]